The European EGPA Study Group was established in 2018 with the intention to create a network of scientists and clinicians from European EGPA referral centers, gathering clinical and scientific excellence and expertise to promote collaborative clinical and translational studies, to enhance knowledge about the disease, and to develop new recommendations…...
Clinical Trial for ANCA-Associated Vasculitis – Now Enrolling Patients
Sites throughout the U.S. and Canada are seeking patients with newly diagnosed or relapsed anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This clinical trial is designed to determine whether a new non-steroidal treatment, when added to standard of care treatment can improve the remission rate, kidney function, and/or improve vasculitis symptoms. All…...
